Outcome of the 269th Board Meeting of the Company held on 29.05.2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Sunil Healthcare Ltd's Board approved audited standalone and consolidated financial results for FY 2025-26 ended March 31, 2026. Standalone revenue grew marginally by ~3% to Rs. 2,183.73 Lakhs from Rs. 2,120.36 Lakhs, while the company slipped into a net loss of Rs. 17.04 Lakhs compared to a profit of Rs. 12.19 Lakhs in the previous year. Consolidated revenue stood at Rs. 8,475.02 Lakhs with a net loss of Rs. 121.57 Lakhs. The auditors issued an unmodified (clean) opinion on the financial statements. The Board did not recommend any dividend for FY 2025-26. An exceptional item of Rs. 946.66 Lakhs was recognized due to inventory/property loss, partially offset by an insurance claim receivable of Rs. 344.35 Lakhs. New internal auditors M/s Agrawal S. Lal & Co. were appointed for FY 2026-27.
The company has shown revenue stability but profitability has deteriorated sharply with both standalone and consolidated operations turning loss-making. The large exceptional item and no dividend recommendation signal financial stress. However, the clean audit opinion provides some comfort to investors.